Tortoise Investment Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-685
Closed -$5.34K 799
2023
Q3
$5.34K Hold
685
﹤0.01% 614
2023
Q2
$5.64K Hold
685
﹤0.01% 610
2023
Q1
$4.97K Hold
685
﹤0.01% 617
2022
Q4
$6.08K Hold
685
﹤0.01% 596
2022
Q3
$8K Hold
685
﹤0.01% 561
2022
Q2
$8K Hold
685
﹤0.01% 544
2022
Q1
$13K Hold
685
﹤0.01% 475
2021
Q4
$18K Hold
685
﹤0.01% 416
2021
Q3
$28K Hold
685
0.01% 341
2021
Q2
$39K Hold
685
0.01% 298
2021
Q1
$29K Hold
685
0.01% 313
2020
Q4
$48K Hold
685
0.01% 245
2020
Q3
$19K Hold
685
﹤0.01% 313
2020
Q2
$20K Hold
685
0.01% 299
2020
Q1
$14K Hold
685
﹤0.01% 332
2019
Q4
$20K Hold
685
﹤0.01% 325
2019
Q3
$16K Hold
685
﹤0.01% 343
2019
Q2
$17K Hold
685
﹤0.01% 363
2019
Q1
$17K Hold
685
﹤0.01% 349
2018
Q4
$16K Hold
685
﹤0.01% 335
2018
Q3
$22K Hold
685
0.01% 310
2018
Q2
$25K Hold
685
0.01% 309
2018
Q1
$23K Hold
685
0.01% 309
2017
Q4
$21K Hold
685
0.01% 315
2017
Q3
$16K Hold
685
﹤0.01% 315
2017
Q2
$11K Hold
685
﹤0.01% 342
2017
Q1
$15K Hold
685
﹤0.01% 292
2016
Q4
$11K Hold
685
﹤0.01% 321
2016
Q3
$9K Buy
+685
New +$14K ﹤0.01% 324

Other funds holding EDIT

Tortoise Investment Management's EDIT Position: Q4 2023 in Review

Tortoise Investment Management sold out of Editas Medicine (EDIT) in Q4 2023, closing a stake of 685 shares — an estimated $5.34K sold.

Tortoise Investment Management first reported a position in EDIT in Q3 2016 and held it in 29 quarters. The position peaked at $48K in Q4 2020. 225 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

  • Tortoise Investment Management reported no remaining Editas Medicine position as of Q4 2023 after selling out during the quarter.
  • Tortoise Investment Management sold 685 Editas Medicine shares in Q4 2023, an estimated $5.34K.
  • Tortoise Investment Management first reported a position in Editas Medicine in Q3 2016 and held it in 29 quarters.
  • Tortoise Investment Management's Editas Medicine position peaked at $48K in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on Tortoise Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.